{"id":382,"date":"1997-05-01T12:07:00","date_gmt":"1997-05-01T10:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1997\/leserbrief-erythrozytapherese-bei-polycythaemia-vera"},"modified":"1997-05-01T12:07:00","modified_gmt":"1997-05-01T10:07:00","slug":"leserbrief-erythrozytapherese-bei-polycythaemia-vera","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1997\/leserbrief-erythrozytapherese-bei-polycythaemia-vera","title":{"rendered":"Leserbrief: Erythrozytapherese bei Polycythaemia vera"},"content":{"rendered":"<p>Zu unserem Artikel &#8222;Neue Aspekte in der medikament\u00f6sen Therapie der Polycythaemia vera&#8220; (AMB 1997, 31, 7) schreiben uns U.K., W.K., K.W.R. und W.H. aus G\u00f6ttingen bzw. M\u00fcnchen (gek\u00fcrzt): >> Wir m\u00f6chten darauf hinweisen, da\u00df bei der Polycythaemia vera (P.v.) die M\u00f6glichkeiten der Erythrozyten-Depletion als prim\u00e4re, m\u00f6glichst alleinige Therapie zur Reduktion der Erythrozytenmasse voll ausgesch\u00f6pft werden [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zu unserem Artikel &#8222;Neue Aspekte in der medikament\u00f6sen Therapie der Polycythaemia vera&#8220; (AMB 1997, 31, 7) schreiben uns U.K., W.K., K.W.R. und W.H. aus G\u00f6ttingen bzw. M\u00fcnchen (gek\u00fcrzt): >> Wir m\u00f6chten darauf hinweisen, da\u00df bei der Polycythaemia vera (P.v.) die M\u00f6glichkeiten der Erythrozyten-Depletion als prim\u00e4re, m\u00f6glichst alleinige Therapie zur Reduktion der Erythrozytenmasse voll ausgesch\u00f6pft werden [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[259,37],"class_list":["post-382","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-erythrozythapherese","tag-polycythaemia-vera"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=382"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/382\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}